Transmembrane protease/serine subfamily member 2 has been widely studied in the context of prostate cancer, where, it is highly expressed, and TMPRSS2 expression is increased in response to androgens through direct transcriptional regulation by the AR (Lin et al., 1999; Lucas et al., 2014). The gene discussed is TMPRSS2; the disease is prostate carcinoma.